{"DataElement":{"publicId":"7197072","version":"1","preferredName":"Category of Drug Accountability Assessment","preferredDefinition":"A grouping of topic-variable values based on sponsor defined characteristics.","longName":"DA_DACAT_RETAMT_SPD","context":"NRDS","contextVersion":"1","DataElementConcept":{"publicId":"6412977","version":"1","preferredName":"Drug Accountability Domain Returned Amount Drug Accountability Record Categorization","preferredDefinition":"A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to drug accountability._The quantity of a product that has been returned._A classification of the drug accountability.","longName":"6407461v1.0:6412975v1.0","context":"NCI Standards","contextVersion":"1","ObjectClass":{"publicId":"6407461","version":"1","preferredName":"Drug Accountability Domain","preferredDefinition":"A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to drug accountability.","longName":"C49578","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Product Accountability Domain","conceptCode":"C49578","definition":"A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to drug and other product accountability.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"73F3E4F1-2F42-2B37-E053-F662850AC5F2","latestVersionIndicator":"Yes","beginDate":"2018-08-21","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-08-21","modifiedBy":"ONEDATA","dateModified":"2018-08-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"6412975","version":"1","preferredName":"Returned Amount Drug Accountability Record Categorization","preferredDefinition":"The quantity of a product that has been returned.:A classification of the drug accountability.","longName":"C78722:C83015","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Returned Amount","conceptCode":"C78722","definition":"The quantity of a product that has been returned.","evsSource":"CTCAE_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Drug Accountability Record Categorization","conceptCode":"C83015","definition":"A classification of the drug accountability.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7436E8D9-C9B3-1C0A-E053-F662850A32BC","latestVersionIndicator":"Yes","beginDate":"2018-08-24","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-08-24","modifiedBy":"ONEDATA","dateModified":"2018-08-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435019","version":"1","preferredName":"Conceptual Entity","preferredDefinition":"An organizational header for concepts representing mostly abstract entities.","longName":"C20181","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D8-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CDISC:Clinical Data Interchange Standards Consortium","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"7436E8D9-C9C4-1C0A-E053-F662850A32BC","latestVersionIndicator":"Yes","beginDate":"2018-08-24","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-08-24","modifiedBy":"KUMMEROA","dateModified":"2021-06-09","changeDescription":"2021-6-9 ak Released per governance approval.; Created as part of the CDISC mapping task_ghd_08.24.18","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"7185246","version":"1","preferredName":"Returned Amount Drug Accountability Record Categorization Clinical Study Sponsor Defined Category","preferredDefinition":"The quantity of a product that has been returned._A classification of the drug accountability._An entity such as an individual, company, institution, group, or organization which takes responsibility for the initiation, management, and/or financing of a clinical study. The sponsor does not actually conduct the investigation unless the sponsor is a sponsor-investigator. A person other than an individual (e.g., corporation or agency) that uses one or more of its own employees to conduct research it has initiated is considered to be a sponsor, and the employees are considered to be investigators. [21 CFR P.50.3(k)] [21 CFR P.50.102(j)] [21 CFR P.312.3]_Clearly characterized or delimited._A grouping of items based on some commonality or by user defined characteristics.","longName":"DACAT_RETAMT_SPD","context":"NRDS","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"200","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"OTHER","valueDescription":"Other","ValueMeaning":{"publicId":"5697874","version":"1","preferredName":"Other","longName":"5697874","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4A253837-4DE2-5542-E053-F662850A338C","latestVersionIndicator":"Yes","beginDate":"2017-03-07","endDate":null,"createdBy":"ALEYR","dateCreated":"2017-03-07","modifiedBy":"GDEEN","dateModified":"2023-12-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9F5EBFC0-D9C3-1CCF-E053-F662850AE91F","beginDate":"2020-02-12","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-02-25","modifiedBy":"ONEDATA","dateModified":"2020-02-25","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435019","version":"1","preferredName":"Conceptual Entity","preferredDefinition":"An organizational header for concepts representing mostly abstract entities.","longName":"C20181","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D8-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"7185245","version":"1","preferredName":"Returned Amount Drug Accountability Record Categorization Clinical Study Sponsor Defined Category","preferredDefinition":"The quantity of a product that has been returned.:A classification of the drug accountability.:An entity such as an individual, company, institution, group, or organization which takes responsibility for the initiation, management, and/or financing of a clinical study. The sponsor does not actually conduct the investigation unless the sponsor is a sponsor-investigator. A person other than an individual (e.g., corporation or agency) that uses one or more of its own employees to conduct research it has initiated is considered to be a sponsor, and the employees are considered to be investigators. [21 CFR P.50.3(k)] [21 CFR P.50.102(j)] [21 CFR P.312.3]:Clearly characterized or delimited.:A grouping of items based on some commonality or by user defined characteristics.","longName":"7185245v1.0","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Returned Amount","conceptCode":"C78722","definition":"The quantity of a product that has been returned.","evsSource":"CTCAE_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Drug Accountability Record Categorization","conceptCode":"C83015","definition":"A classification of the drug accountability.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Clinical Study Sponsor","conceptCode":"C70793","definition":"An entity such as an individual, company, institution, group, or organization which takes responsibility for the initiation, management, and/or financing of a clinical study. The sponsor does not actually conduct the investigation unless the sponsor is a sponsor-investigator. A person other than an individual (e.g., corporation or agency) that uses one or more of its own employees to conduct research it has initiated is considered to be a sponsor, and the employees are considered to be investigators. [21 CFR P.50.3(k)] [21 CFR P.50.102(j)] [21 CFR P.312.3]","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Defined","conceptCode":"C165683","definition":"Clearly characterized or delimited.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Category","conceptCode":"C25372","definition":"A grouping of items based on some commonality or by user defined characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F5EBFC0-D99C-1CCF-E053-F662850AE91F","latestVersionIndicator":"Yes","beginDate":"2020-02-25","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-02-25","modifiedBy":"ONEDATA","dateModified":"2020-02-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CDISC:Clinical Data Interchange Standards Consortium","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"9F5EBFC0-D9AD-1CCF-E053-F662850AE91F","latestVersionIndicator":"Yes","beginDate":"2020-02-25","endDate":"2022-07-12","createdBy":"TAYLORT","dateCreated":"2020-02-25","modifiedBy":"GDEEN","dateModified":"2022-07-14","changeDescription":"2/25/20 Created to support sponsor defined codelists; tmt.","administrativeNotes":"07.14.22_Released during quarterly metrics and per request from G. Riley_ghd","unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"5858962","version":"1","longName":"Under Review","context":"NRDS","ClassificationSchemeItems":[{"publicId":"7066596","version":"1","longName":"CDISC (NRDS Implementation)","context":"NRDS"},{"publicId":"7067375","version":"1","longName":"Sponsor Defined","context":"NRDS"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"What was the type of treatmen","type":"Preferred Question Text","description":"What was the type of treatment returned?","url":null,"context":"NRDS"},{"name":"CDASH PROMPT","type":"Alternate Question Text","description":"Treatment Type","url":null,"context":"NRDS"},{"name":"DACAT","type":"CDASH to SDTM Mapping","description":"Maps directly to the SDTMIG variable.","url":null,"context":"NRDS"},{"name":"Case Report Form Completion Instructions","type":"CDISC CRF Instruction","description":"Record the type of study treatment returned (e.g., STUDY MEDICATION, RESCUE MEDICATION, COMPARATOR, PLACEBO).","url":null,"context":"NRDS"},{"name":"CDASH Implementation Notes","type":"CDASH Implementation Note","description":"Sponsor-defined Controlled Terminology. This would most commonly be pre-printed on the CRF or screen and pre-populated in the data management system. This is not typically a question to which the site would provide an answer. If the protocol allows dispensing different types of study treatment (e.g., study medication, rescue medication, run-in medication) the CRF can capture the type of treatment using DACAT. This may be pre-printed on the CRF. If DACAT is not collected (e.g., it is self-evident from the protocol design), it could be populated during the SDTM-based dataset creation process. This CDASH variable name is an example of what \"variable name\" can be used in a denormalized data structure.","url":null,"context":"NRDS"}],"origin":"CDISC:Clinical Data Interchange Standards Consortium","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"A06DBB8F-D285-0CCF-E053-F662850AF522","latestVersionIndicator":"Yes","beginDate":"2020-03-09","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-03-09","modifiedBy":"GDEEN","dateModified":"2022-07-14","changeDescription":"3-9-20 tmt created for sponsor-defined codelists.","administrativeNotes":"07.14.22_Released as part of the quarterly metrics and per request of G. Riley_ghd","unresolvedIssues":null,"deletedIndicator":"No"}}